# Cardinal Health vs Takeda Pharmaceutical: stocks compared

URL: https://funkfolio.com/compare/cah-vs-tak

> Cardinal Health ($64.5B, P/E 36.7) and Takeda Pharmaceutical ($69.1B, P/E 309) compared: size, valuation, margins, debt, cash and price change.

---

## Cardinal Health vs Takeda Pharmaceutical

Cardinal Health (CAH), health care, and Takeda Pharmaceutical (TAK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Takeda Pharmaceutical is worth $69.1B on the stock market and Cardinal Health $64.5B: Takeda Pharmaceutical is valued at 7% more. Cardinal Health trades at 36.7 times earnings and Takeda Pharmaceutical at 309; operating margins in their latest fiscal years were 1.03% and 0.14%. Over the past year Cardinal Health's share price has moved +37.1% and Takeda Pharmaceutical's +53.4%.

### Key facts

- **Cardinal Health market value:** $64.5B
- **Takeda Pharmaceutical market value:** $69.1B
- **Cardinal Health P/E:** 36.7
- **Takeda Pharmaceutical P/E:** 309
- **Cardinal Health revenue:** $254.2B FY to 2026-06-30
- **Takeda Pharmaceutical revenue:** $28.2B FY to 2026-03-31
- **Superinvestors holding both:** 1

Market values as of 18 Nov 2026, 05:03 UTC.

Cardinal Health vs Takeda Pharmaceutical: every measure side by side

| Measure | Cardinal Health | Takeda Pharmaceutical |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | Japan |
| Fiscal year ends | 2026-06-30 | 2026-03-31 |
| Size |  |  |
| Market cap | $64.5B lower | $69.1B higher |
| Revenue | $254.2B higher | $28.2B lower |
| Earnings | $1.7B higher | -$954.4M lower |
| Employees | 58,788 higher | 47,029 lower |
| Total assets | $57.3B lower | $97.1B higher |
| Valuation |  |  |
| P/E | 36.7 lower | 309 higher |
| P/S | 0.3 lower | 2.5 higher |
| P/B | — | — |
| Dividend yield | 0.72% | — |
| Profitability |  |  |
| Operating margin | 1.03% higher | 0.14% lower |
| Balance sheet |  |  |
| Net assets | -$2.9B lower | $46.5B higher |
| Total liabilities | $60B higher | $50.6B lower |
| Total debt | $8.9B lower | $30.6B higher |
| Cash on hand | $4.9B higher | $3.7B lower |
| Price change |  |  |
| Today | -1.62% lower | +0.23% higher |
| 1 year | +37.1% lower | +53.4% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Cardinal Health 135.4, Takeda Pharmaceutical 153.0.

- Cardinal Health (CAH)
- Takeda Pharmaceutical (TAK)

Cardinal Health and Takeda Pharmaceutical share prices over one year, rebased to 100: Cardinal Health ends at 135.4, Takeda Pharmaceutical at 153.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | CAH | TAK |
| --- | --- | --- |
| Nov 28, 2025 | 102.9 | 102.0 |
| Dec 31, 2025 | 99.7 | 110.3 |
| Jan 30, 2026 | 104.2 | 121.9 |
| Feb 27, 2026 | 111.2 | 132.6 |
| Mar 31, 2026 | 102.5 | 131.0 |
| Apr 30, 2026 | 93.5 | 118.0 |
| May 29, 2026 | 95.5 | 112.9 |
| Jun 30, 2026 | 115.2 | 113.4 |
| Jul 31, 2026 | 111.6 | 120.9 |
| Aug 31, 2026 | 113.8 | 127.2 |
| Sep 30, 2026 | 107.9 | 128.6 |
| Oct 30, 2026 | 121.5 | 147.9 |
| Nov 17, 2026 | 135.4 | 153.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (1)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.4% / 0.5%

#### Cardinal Health only (5)

- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.1%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.1%
- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 0.1%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.1%

#### Takeda Pharmaceutical only (1)

- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Cardinal Health / Takeda Pharmaceutical). [Who owns CAH](https://funkfolio.com/stock/CAH/superinvestors) · [Who owns TAK](https://funkfolio.com/stock/TAK/superinvestors)

### More on Cardinal Health

- [Cardinal Health (CAH) stock page](https://funkfolio.com/stock/CAH)
- [Cardinal Health market cap](https://funkfolio.com/stock/CAH/market-cap)
- [Cardinal Health revenue](https://funkfolio.com/stock/CAH/revenue)
- [Cardinal Health P/E ratio](https://funkfolio.com/stock/CAH/pe-ratio)
- [Cardinal Health operating margin](https://funkfolio.com/stock/CAH/operating-margin)
- [Cardinal Health total debt](https://funkfolio.com/stock/CAH/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Takeda Pharmaceutical

- [Takeda Pharmaceutical (TAK) stock page](https://funkfolio.com/stock/TAK)
- [Takeda Pharmaceutical market cap](https://funkfolio.com/stock/TAK/market-cap)
- [Takeda Pharmaceutical revenue](https://funkfolio.com/stock/TAK/revenue)
- [Takeda Pharmaceutical P/E ratio](https://funkfolio.com/stock/TAK/pe-ratio)
- [Takeda Pharmaceutical operating margin](https://funkfolio.com/stock/TAK/operating-margin)
- [Takeda Pharmaceutical total debt](https://funkfolio.com/stock/TAK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Cardinal Health against its closest peers

- [Cardinal Health vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-cah)
- [Cardinal Health vs argenx](https://funkfolio.com/compare/argx-vs-cah)
- [Cardinal Health vs Edwards Lifesciences](https://funkfolio.com/compare/cah-vs-ew)
- [Cardinal Health vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-cah)

#### Takeda Pharmaceutical against its closest peers

- [Takeda Pharmaceutical vs Cencora](https://funkfolio.com/compare/cor-vs-tak)
- [Takeda Pharmaceutical vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-tak)
- [Takeda Pharmaceutical vs argenx](https://funkfolio.com/compare/argx-vs-tak)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Cardinal Health or Takeda Pharmaceutical?**

By market value, Takeda Pharmaceutical is the larger: $69.1B against $64.5B for Cardinal Health. By revenue in its latest fiscal year, Cardinal Health is the larger: $254.2B against $28.2B for Takeda Pharmaceutical.

**Which has the higher P/E ratio?**

Takeda Pharmaceutical: 309, against 36.7 for Cardinal Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Cardinal Health: 1.03%, against 0.14% for Takeda Pharmaceutical. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Takeda Pharmaceutical: $30.6B, against $8.9B for Cardinal Health. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Cardinal Health and Takeda Pharmaceutical?**

In their latest 13F filings, Charles Brandes (founder) holds both.

### Cite this page

Funkfolio, “Cardinal Health vs Takeda Pharmaceutical”, data as of 18 November 2026. https://funkfolio.com/compare/cah-vs-tak

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
